GE Healthcare files patent lawsuit against Bio-Rad

American conglomerate GE Healthcare (GE) last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

GE to sell biopharma unit to Danaher for $21.4 billion

28 February 2019 General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.

Americas

GE Healthcare partners with Vanderbilt University to create AI apps

17 January 2019 US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.

Americas

GE life sciences expansion costs $1.06 billion

13 January 2014 General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

GE Healthcare files patent lawsuit against Bio-Rad

More on this story

Editor's picks

Editor's picks

More features